Ocugen Inc (OCGN)
1.315
-0.08
(-5.40%)
USD |
NASDAQ |
Apr 30, 16:00
1.315
0.00 (0.00%)
After-Hours: 20:00
Ocugen Cash from Investing (Quarterly): -2.722M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.722M |
| September 30, 2023 | -3.365M |
| June 30, 2023 | 5.723M |
| March 31, 2023 | 3.441M |
| December 31, 2022 | -15.30M |
| September 30, 2022 | -0.083M |
| June 30, 2022 | -1.366M |
| March 31, 2022 | -0.223M |
| December 31, 2021 | -0.192M |
| September 30, 2021 | -0.35M |
| June 30, 2021 | -1.013M |
| March 31, 2021 | -0.261M |
| December 31, 2020 | -0.251M |
| September 30, 2020 | -0.022M |
| June 30, 2020 | 0.019M |
| March 31, 2020 | -0.053M |
| December 31, 2019 | -0.0209M |
| September 30, 2019 | -2.446M |
| June 30, 2019 | 0.11M |
| March 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | -0.073M |
| September 30, 2018 | 0.794M |
| June 30, 2018 | -1.479M |
| March 31, 2018 | -0.355M |
| December 31, 2017 | 0.747M |
| September 30, 2017 | 6.104M |
| June 30, 2017 | -0.038M |
| March 31, 2017 | -8.043M |
| December 31, 2016 | -0.003M |
| September 30, 2016 | -0.003M |
| June 30, 2016 | -0.282M |
| March 31, 2016 | -0.032M |
| December 31, 2015 | -0.131M |
| September 30, 2015 | -0.498M |
| June 30, 2015 | -0.405M |
| March 31, 2015 | -0.915M |
| December 31, 2014 | -1.744M |
| September 30, 2014 | -1.384M |
| June 30, 2014 | -0.073M |
| March 31, 2014 | -0.12M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-15.30M
Minimum
Dec 2022
5.723M
Maximum
Jun 2023
-0.9668M
Average
-0.223M
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -1.202B |
| QuidelOrtho Corp | -55.10M |
| Akebia Therapeutics Inc | 0.00 |
| Shockwave Medical Inc | -242.26M |
| iBio Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.30M |
| Cash from Financing (Quarterly) | 0.016M |
| Free Cash Flow | -72.53M |
| Free Cash Flow Per Share (Quarterly) | -0.0546 |
| Free Cash Flow to Equity (Quarterly) | -14.05M |
| Free Cash Flow Yield | -22.58% |